Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Personalized craving scale shows promise for addiction treatment

NCT ID NCT03606759

Symptom relief Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a personalized therapy scale to standard treatment helps reduce cravings in people with substance use disorders or behavioral addictions like gambling. 151 adults seeking outpatient care participated. The approach aimed to tailor treatment to each person's unique triggers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

151 people

The number who actually took part.

Started

Jul 2019

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * 18 years old or older * Meet DSM-5 substance use disorder diagnosis for at least one substance (alcohol, tobacco, cannabis, opiates, cocaine or any other substance) use disorder or behavioral addiction (gambling, screens, video games, food addiction, sex addiction, compulsive purchases), currently not stabilized * Seek treatment for this a substance use disorder or behavioral addiction * Beginning (or re-initiating) multi-month outpatient care for this disorder in one of the inclusion centres. * Ability to identify a priority substance/behavior, as main object of treatment, in case of simultaneous treatment on several addictions * Beneficiary of the French Social Security system * Give an informed consent to participate o Exclusion criteria: * Severe physical or psychiatric or addictologic condition that prevents an outpatient treatment * Severe physical or psychiatric condition that prevents to complete the assessment * Addictive disorder that requires several treatment for several substance use disorder simultaneously * Difficulty to understand and to write French * Could not be reachable by phone * Participate to another study that prevents to participate to another research * Prisoner * Person under law protection * Person under legal guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Addictive behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior, Addictive substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Addictive behavior Substance-related disorders

Contacts and locations

Locations

  • Bordeaux University Hospital

    Bordeaux, 33076, France

  • Centre Hospitalier Charles Perrens

    Bordeaux, 33076, France

  • Centre Hospitalier Esquirol

    Limoges, 87 025, France

  • Centre Hospitalier Universitaire La Réunion

    Saint-Denis, 97 405, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.